User menu

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Bibliographic reference Sissoko, Daouda ; Laouenan, Cedric ; Folkesson, Elin ; M’Lebing, Abdoul-Bing ; Beavogui, Abdoul-Habib ; et. al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. In: PLoS Medicine, Vol. 13, no.3, p. e1001967 (2016)
Permanent URL http://hdl.handle.net/2078.1/173111
  1. Baize Sylvain, Pannetier Delphine, Oestereich Lisa, Rieger Toni, Koivogui Lamine, Magassouba N'Faly, Soropogui Barrè, Sow Mamadou Saliou, Keïta Sakoba, De Clerck Hilde, Tiffany Amanda, Dominguez Gemma, Loua Mathieu, Traoré Alexis, Kolié Moussa, Malano Emmanuel Roland, Heleze Emmanuel, Bocquin Anne, Mély Stephane, Raoul Hervé, Caro Valérie, Cadar Dániel, Gabriel Martin, Pahlmann Meike, Tappe Dennis, Schmidt-Chanasit Jonas, Impouma Benido, Diallo Abdoul Karim, Formenty Pierre, Van Herp Michel, Günther Stephan, Emergence of Zaire Ebola Virus Disease in Guinea, 10.1056/nejmoa1404505
  2. Kuhn Jens, Andersen Kristian, Baize Sylvain, Bào Yīmíng, Bavari Sina, Berthet Nicolas, Blinkova Olga, Brister J., Clawson Anna, Fair Joseph, Gabriel Martin, Garry Robert, Gire Stephen, Goba Augustine, Gonzalez Jean-Paul, Günther Stephan, Happi Christian, Jahrling Peter, Kapetshi Jimmy, Kobinger Gary, Kugelman Jeffrey, Leroy Eric, Maganga Gael, Mbala Placide, Moses Lina, Muyembe-Tamfum Jean-Jacques, N'Faly Magassouba, Nichol Stuart, Omilabu Sunday, Palacios Gustavo, Park Daniel, Paweska Janusz, Radoshitzky Sheli, Rossi Cynthia, Sabeti Pardis, Schieffelin John, Schoepp Randal, Sealfon Rachel, Swanepoel Robert, Towner Jonathan, Wada Jiro, Wauquier Nadia, Yozwiak Nathan, Formenty Pierre, Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014, 10.3390/v6114760
  3. Wkly Epidemiol Rec, 90, 89 (2015)
  4. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot M-C, Lansoud-Soukate J, Capron M, Debré P, Georges AJ, McCormick JB, Human asymptomatic Ebola infection and strong inflammatory response, 10.1016/s0140-6736(00)02405-3
  5. Feldmann Heinz, Geisbert Thomas W, Ebola haemorrhagic fever, 10.1016/s0140-6736(10)60667-8
  6. West T. Eoin, von Saint André-von Arnim Amélie, Clinical Presentation and Management of Severe Ebola Virus Disease, 10.1513/annalsats.201410-481ps
  7. Schieffelin John S., Shaffer Jeffrey G., Goba Augustine, Gbakie Michael, Gire Stephen K., Colubri Andres, Sealfon Rachel S.G., Kanneh Lansana, Moigboi Alex, Momoh Mambu, Fullah Mohammed, Moses Lina M., Brown Bethany L., Andersen Kristian G., Winnicki Sarah, Schaffner Stephen F., Park Daniel J., Yozwiak Nathan L., Jiang Pan-Pan, Kargbo David, Jalloh Simbirie, Fonnie Mbalu, Sinnah Vandi, French Issa, Kovoma Alice, Kamara Fatima K., Tucker Veronica, Konuwa Edwin, Sellu Josephine, Mustapha Ibrahim, Foday Momoh, Yillah Mohamed, Kanneh Franklyn, Saffa Sidiki, Massally James L.B., Boisen Matt L., Branco Luis M., Vandi Mohamed A., Grant Donald S., Happi Christian, Gevao Sahr M., Fletcher Thomas E., Fowler Robert A., Bausch Daniel G., Sabeti Pardis C., Khan S. Humarr, Garry Robert F., Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone, 10.1056/nejmoa1411680
  8. Stephens David S., Ribner Bruce S., Gartland Bryce D., Feistritzer Nancye R., Farley Monica M., Larsen Christian P., Fox John T., Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa, 10.1371/journal.pmed.1001857
  9. Lyon G. Marshall, Mehta Aneesh K., Varkey Jay B., Brantly Kent, Plyler Lance, McElroy Anita K., Kraft Colleen S., Towner Jonathan S., Spiropoulou Christina, Ströher Ute, Uyeki Timothy M., Ribner Bruce S., Clinical Care of Two Patients with Ebola Virus Disease in the United States, 10.1056/nejmoa1409838
  10. Mora-Rillo Marta, Arsuaga Marta, Ramírez-Olivencia Germán, de la Calle Fernando, Borobia Alberto M, Sánchez-Seco Paz, Lago Mar, Figueira Juan C, Fernández-Puntero Belén, Viejo Aurora, Negredo Anabel, Nuñez Concepción, Flores Eva, Carcas Antonio J, Jiménez-Yuste Victor, Lasala Fátima, García-de-Lorenzo Abelardo, Arnalich Francisco, Arribas Jose R, Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain, 10.1016/s2213-2600(15)00180-0
  11. World Health Organization. Categorization and prioritization of drugs for consideration for testing or use in patients infected with Ebola. 2015 Jan 19 [cited 15 Sep 2015]. Available: http://www.who.int/medicines/ebola-treatment/cat_prioritization_drugs_testing/en/.
  12. Smither Sophie J., Eastaugh Lin S., Steward Jackie A., Nelson Michelle, Lenk Robert P., Lever Mark S., Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model, 10.1016/j.antiviral.2014.01.012
  13. Furuta Yousuke, Gowen Brian B., Takahashi Kazumi, Shiraki Kimiyasu, Smee Donald F., Barnard Dale L., Favipiravir (T-705), a novel viral RNA polymerase inhibitor, 10.1016/j.antiviral.2013.09.015
  14. Furuta Y., Takahashi K., Fukuda Y., Kuno M., Kamiyama T., Kozaki K., Nomura N., Egawa H., Minami S., Watanabe Y., Narita H., Shiraki K., In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, 10.1128/aac.46.4.977-981.2002
  15. Oestereich Lisa, Lüdtke Anja, Wurr Stephanie, Rieger Toni, Muñoz-Fontela César, Günther Stephan, Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model, 10.1016/j.antiviral.2014.02.014
  16. MDVI. Phase 3 efficacy and safety study of favipiravir for treatment of uncomplicated influenza in Adults. ClinicalTrials.gov. 2013 Dec 8 [cited 15 Sep 2015]. Available: https://clinicaltrials.gov/ct2/show/NCT02008344.
  17. Madelain Vincent, Oestereich Lisa, Graw Frederik, Nguyen Thi Huyen Tram, de Lamballerie Xavier, Mentré France, Günther Stephan, Guedj Jeremie, Ebola virus dynamics in mice treated with favipiravir, 10.1016/j.antiviral.2015.08.015
  18. Mentré France, Taburet Anne-Marie, Guedj Jeremie, Anglaret Xavier, Keïta Sakoba, de Lamballerie Xavier, Malvy Denis, Dose regimen of favipiravir for Ebola virus disease, 10.1016/s1473-3099(14)71047-3
  19. Bouazza Naïm, Treluyer Jean-Marc, Foissac Frantz, Mentré France, Taburet Anne-Marie, Guedj Jérémie, Anglaret Xavier, de Lamballerie Xavier, Keïta Sakoba, Malvy Denis, Frange Pierre, Favipiravir for children with Ebola, 10.1016/s0140-6736(15)60232-x
  20. Rowe Alexander K., Bertolli Jeanne, Khan Ali S., Mukunu Rose, Muyembe‐Tamfum J. J., Bressler David, Williams A. J., Peters C. J., Rodriguez Luis, Feldmann Heinz, Nichol Stuart T., Rollin Pierre E., Ksiazek Thomas G., , Clinical, Virologic, and Immunologic Follow‐Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the Congo, 10.1086/514318
  21. Ksiazek T. G., Rollin P. E., Williams A. J., Bressler D. S., Martin M. L., Swanepoel R., Burt F. J., Leman P. A., Khan A. S., Rowe A. K., Mukunu R., Sanchez A., Peters C. J., Clinical Virology of Ebola Hemorrhagic Fever (EHF): Virus, Virus Antigen, and IgG and IgM Antibody Findings among EHF Patients in Kikwit, Democratic Republic of the Congo, 1995, 10.1086/514321
  22. Towner J. S., Rollin P. E., Bausch D. G., Sanchez A., Crary S. M., Vincent M., Lee W. F., Spiropoulou C. F., Ksiazek T. G., Lukwiya M., Kaducu F., Downing R., Nichol S. T., Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome, 10.1128/jvi.78.8.4330-4341.2004
  23. Kourtis Athena P., Appelgren Kristie, Chevalier Michelle S., McElroy Anita, Ebola Virus Disease : Focus on Children, 10.1097/inf.0000000000000707
  24. Rollin Pierre E., Bausch Daniel G., Sanchez Anthony, Blood Chemistry Measurements andd‐Dimer Levels Associated with Fatal and Nonfatal Outcomes in Humans Infected with Sudan Ebola Virus, 10.1086/520613
  25. Kortepeter Mark G., Bausch Daniel G., Bray Mike, Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever, 10.1093/infdis/jir299
  26. Bah Elhadj Ibrahima, Lamah Marie-Claire, Fletcher Tom, Jacob Shevin T., Brett-Major David M., Sall Amadou Alpha, Shindo Nahoko, Fischer William A., Lamontagne Francois, Saliou Sow Mamadou, Bausch Daniel G., Moumié Barry, Jagatic Tim, Sprecher Armand, Lawler James V., Mayet Thierry, Jacquerioz Frederique A., Méndez Baggi María F., Vallenas Constanza, Clement Christophe, Mardel Simon, Faye Ousmane, Faye Oumar, Soropogui Baré, Magassouba Nfaly, Koivogui Lamine, Pinto Ruxandra, Fowler Robert A., Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea, 10.1056/nejmoa1411249
  27. ACAPS. Ebola in West Africa—Guinea: resistance to the Ebola response. ACAPS Thematic Note. 2015 Apr 24 [cited 15 Sep 2015]. Available: http://acaps.org/img/documents/t-acaps_ebola_guinea-resistance-to-ebola-response_24-april-2015.pdf.
  28. Calain Philippe, Poncin Marc, Reaching out to Ebola victims: Coercion, persuasion or an appeal for self-sacrifice?, 10.1016/j.socscimed.2015.10.063
  29. Presidential Commission for the Study of Bioethical Issues. Ethics and Ebola: public health planning and response. 2015 Feb [cited 28 Jan 2015]. Available: http://bioethics.gov/sites/default/files/Ethics-and-Ebola_PCSBI_508.pdf.
  30. Huang Yi, Wei Hongping, Wang Yunpeng, Shi Zhengli, Raoul Herve, Yuan Zhiming, Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays, 10.1007/s12250-012-3252-y
  31. Tam Nguyen Thanh, Huy Nguyen Tien, Thoa Le Thi Bich, Long Nguyen Phuoc, Trang Nguyen Thi Huyen, Hirayama Kenji, Karbwang Juntra, Participants’ understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis, 10.2471/blt.14.141390
  32. J Whitehead (1997)
  33. Newcombe Robert G., Two-sided confidence intervals for the single proportion: comparison of seven methods, 10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e
  34. Hidalgo Bertha, Goodman Melody, Multivariate or Multivariable Regression?, 10.2105/ajph.2012.300897
  35. Copas J. B., Plotting p against x, 10.2307/2348040
  36. Sissoko S, Folkesson E, Abdoul M, Beavogui A, Gunther S, Shepherd S, et al. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Abstract 103-ALB. 22nd Conference on Retroviruses and Opportunistic Infections; 23–26 Feb 2015; Seattle, Washington, US. Available: http://www.croiconference.org/sessions/favipiravir-patients-ebola-virus-disease-early-results-jiki-trial-guinea.
  37. Kuhn E., Lavielle M., Maximum likelihood estimation in nonlinear mixed effects models, 10.1016/j.csda.2004.07.002
  38. KR Victory, MMWR Morb Mortal Wkly Rep, 64, 386 (2015)
  39. Lanini Simone, Zumla Alimuddin, Ioannidis John P A, Caro Antonino Di, Krishna Sanjeev, Gostin Lawrence, Girardi Enrico, Pletschette Michel, Strada Gino, Baritussio Aldo, Portella Gina, Apolone Giovanni, Cavuto Silvio, Satolli Roberto, Kremsner Peter, Vairo Francesco, Ippolito Giuseppe, Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?, 10.1016/s1473-3099(15)70106-4
  40. Joffe Steven, Evaluating Novel Therapies During the Ebola Epidemic, 10.1001/jama.2014.12867
  41. Chimerix. An open-label, multicenter study of the safety and anti viral activity of brincidofovir (BCV, CMX001) for Ebola virus disease. ClinicalTrials.gov. 2014 Oct 7 [cited 15 Sep 2015]. Available: https://clinicaltrials.gov/ct2/show/NCT02271347.
  42. van Griensven Johan, Edwards Tansy, de Lamballerie Xavier, Semple Malcolm G., Gallian Pierre, Baize Sylvain, Horby Peter W., Raoul Hervé, Magassouba N’Faly, Antierens Annick, Lomas Carolyn, Faye Ousmane, Sall Amadou A., Fransen Katrien, Buyze Jozefien, Ravinetto Raffaella, Tiberghien Pierre, Claeys Yves, De Crop Maaike, Lynen Lutgarde, Bah Elhadj Ibrahima, Smith Peter G., Delamou Alexandre, De Weggheleire Anja, Haba Nyankoye, Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea, 10.1056/nejmoa1511812
  43. National Institute of Allergy and Infectious Diseases. Putative investigational therapeutics in the treatment of patients with known Ebola infection. ClinicalTrials.gov. 2015 Feb 13 [cited 15 Sep 2015]. Available at: https://clinicaltrials.gov/ct2/show/NCT02363322.
  44. X Qiu, Nature, 514, 47 (2014)
  45. Cooper Ben S., Boni Maciej F., Pan-ngum Wirichada, Day Nicholas P. J., Horby Peter W., Olliaro Piero, Lang Trudie, White Nicholas J., White Lisa J., Whitehead John, Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease, 10.1371/journal.pmed.1001815
  46. Adebamowo Clement, Bah-Sow Oumou, Binka Fred, Bruzzone Roberto, Caplan Arthur, Delfraissy Jean-François, Heymann David, Horby Peter, Kaleebu Pontiano, Tamfum Jean-Jacques Muyembe, Olliaro Piero, Piot Peter, Tejan-Cole Abdul, Tomori Oyewale, Toure Aissatou, Torreele Els, Whitehead John, Randomised controlled trials for Ebola: practical and ethical issues, 10.1016/s0140-6736(14)61734-7
  47. Sanchez A., Lukwiya M., Bausch D., Mahanty S., Sanchez A. J., Wagoner K. D., Rollin P. E., Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels, 10.1128/jvi.78.19.10370-10377.2004
  48. McElroy A. K., Erickson B. R., Flietstra T. D., Rollin P. E., Nichol S. T., Towner J. S., Spiropoulou C. F., Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome, 10.1093/infdis/jiu088
  49. Fitzpatrick Gabriel, Vogt Florian, Moi Gbabai Osman B., Decroo Tom, Keane Marian, De Clerck Hilde, Grolla Allen, Brechard Raphael, Stinson Kathryn, Van Herp Michel, The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014, 10.1093/infdis/jiv304
  50. Hunt Luke, Gupta-Wright Ankur, Simms Victoria, Tamba Fayia, Knott Victoria, Tamba Kongoneh, Heisenberg-Mansaray Saidu, Tamba Emmanuel, Sheriff Alpha, Conteh Sulaiman, Smith Tom, Tobin Shelagh, Brooks Tim, Houlihan Catherine, Cummings Rachael, Fletcher Tom, Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study, 10.1016/s1473-3099(15)00144-9
  51. Schibler Manuel, Vetter Pauline, Cherpillod Pascal, Petty Tom J, Cordey Samuel, Vieille Gaël, Yerly Sabine, Siegrist Claire-Anne, Samii Kaveh, Dayer Julie-Anne, Docquier Mylène, Zdobnov Evgeny M, Simpson Andrew J H, Rees Paul S C, Sarria Felix Baez, Gasche Yvan, Chappuis François, Iten Anne, Pittet Didier, Pugin Jérôme, Kaiser Laurent, Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report, 10.1016/s1473-3099(15)00229-7
  52. Angus Derek C., van der Poll Tom, Severe Sepsis and Septic Shock, 10.1056/nejmra1208623
  53. Bellomo Rinaldo, Kellum John A, Ronco Claudio, Acute kidney injury, 10.1016/s0140-6736(11)61454-2
  54. Crum-Cianflone N. F., Bacterial, Fungal, Parasitic, and Viral Myositis, 10.1128/cmr.00001-08
  55. Konrad Robert J., Tumor Necrosis Factor and Coxsackie B4 Rhabdomyolysis, 10.7326/0003-4819-119-8-199310150-00024
  56. C Naylor, CMAJ, 137, 819 (1987)
  57. Bosch Xavier, Poch Esteban, Grau Josep M., Rhabdomyolysis and Acute Kidney Injury, 10.1056/nejmra0801327
  58. Ramanan Parameshwaran, Shabman Reed S., Brown Craig S., Amarasinghe Gaya K., Basler Christopher F., Leung Daisy W., Filoviral Immune Evasion Mechanisms, 10.3390/v3091634
  59. Ramanan P., Edwards M. R., Shabman R. S., Leung D. W., Endlich-Frazier A. C., Borek D. M., Otwinowski Z., Liu G., Huh J., Basler C. F., Amarasinghe G. K., Structural basis for Marburg virus VP35-mediated immune evasion mechanisms, 10.1073/pnas.1213559109
  60. Broadhurst Mara Jana, Kelly John Daniel, Miller Ann, Semper Amanda, Bailey Daniel, Groppelli Elisabetta, Simpson Andrew, Brooks Tim, Hula Susan, Nyoni Wilfred, Sankoh Alhaji B, Kanu Santigi, Jalloh Alhaji, Ton Quy, Sarchet Nicholas, George Peter, Perkins Mark D, Wonderly Betsy, Murray Megan, Pollock Nira R, ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study, 10.1016/s0140-6736(15)61042-x
  61. Gowen Brian B., Sefing Eric J., Westover Jonna B., Smee Donald F., Hagloch Joseph, Furuta Yousuke, Hall Jeffery O., Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever, 10.1016/j.antiviral.2015.07.003
  62. Varghese Julie M., Roberts Jason A., Lipman Jeffrey, Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock, 10.1016/j.ccc.2010.09.006